← back to search

Kristin N. Nelson

Emory University · US
Area of research
Infectious Diseases · Modeling and Simulation · Machi
Research interest
Research interests include COVID-19 epidemiological studies, Tuberculosis Research and Epidemiology, Vaccine Coverage and Hesitancy, and SARS-CoV-2 and COVID-19 Research.
h-index
22
citations
1,981
works
92
NIH funding
primary concept
Medicine
email

Recent publications

Estimating modern US social contact patterns, the ENGAGED study: a study protocol for a staggered longitudinal cohort study.
2026cited by 0position: contributordoi
Mycobacterium tuberculosis transmission in China during the COVID-19 pandemic period (2020–2021) compared with the pre-pandemic period (2017–2019)
Nature Communications 2025cited by 1position: middledoi
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?
The Lancet Microbe 2023cited by 4position: firstdoi
Nationally representative social contact patterns among U.S. adults, August 2020-April 2021
Epidemics 2022cited by 36position: firstdoi
Rapid Review of Social Contact Patterns During the COVID-19 Pandemic
Epidemiology 2021cited by 147position: lastdoi
Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System
Annals of Internal Medicine 2021cited by 100position: middledoi
Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies
Epidemiology 2021cited by 94position: middledoi
Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020
Clinical Infectious Diseases 2021cited by 43position: middledoi
Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA
Proceedings of the National Academy of Sciences 2020cited by 242position: middledoi
Prenatal and early-life exposure to the Great Chinese Famine increased the risk of tuberculosis in adulthood across two generations
Proceedings of the National Academy of Sciences 2020cited by 55position: middledoi
Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates
Nature Medicine 2020cited by 45position: middledoi
Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa
Proceedings of the National Academy of Sciences 2019cited by 33position: middledoi
Extensively drug-resistant tuberculosis ‘hotspots' and sociodemographic associations in Durban, South Africa
The International Journal of Tuberculosis and Lung Disease 2019cited by 26position: middledoi
Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa
The Journal of Infectious Diseases 2018cited by 38position: firstdoi
Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities
European Respiratory Journal 2018cited by 35position: middledoi
Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV-positive, treatment-naive U.S. veterans
AIDS 2016cited by 56position: firstdoi
Attitudes towards new tuberculosis vaccines among adults, adolescents and their caregivers in southern Mozambique, 2024
cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Benjamin A. Lopman · Emory University7 papers (2021–2026)Sara C. Auld · Emory University4 papers (2018–2019)Koleka Mlisana · National Health Laboratory Service4 papers (2018–2019)Aaron J. Siegler · Emory University4 papers (2021–2026)Nazir Ismail · National Health Laboratory Service4 papers (2018–2019)Neel R. Gandhi · Emory University4 papers (2018–2019)Neha Shah · Walter Reed Army Institute of Research4 papers (2018–2019)Barun Mathema · Boston University4 papers (2018–2019)James C.M. Brust · Albert Einstein College of Medicine4 papers (2018–2019)Kayoko Shioda · Boston University3 papers (2021–2022)Pravi Moodley · National Health Laboratory Service3 papers (2018–2019)Patrick S. Sullivan · Proteogenomics Research Institute for Systems Medicine3 papers (2021–2022)Salim Allana · Aga Khan University Hospital3 papers (2018–2019)Tyler S. Brown · Boston University3 papers (2018–2019)Shaheed Vally Omar · National Institute for Communicable Diseases3 papers (2018–2019)Heather Bradley · Public Health – Seattle & King County2 papers (2021–2022)Alicia N.M. Kraay · Gates Foundation2 papers (2020–2021)Eric Hall · Emory University2 papers (2021–2022)Max S. Y. Lau · Emory University2 papers (2020–2021)Angela Campbell · Centers for Disease Control and Prevention2 papers (2018–2019)